G1 Therapeutics Inc at Raymond James Human Health Innovation Conference (Virtual) Transcript
Welcome, everyone, to day 2 of the Raymond James 2021 Human Health Innovation Conference. My name is Dane Leone, one of the senior biotech analysts at the Raymond James team. For this session, we are going to have a fireside chat with the leadership team of G1 Therapeutics. The ticker is GTHX. Very excited to have the CEO, Jack Bailey, with me; and Rajesh Malik, who is the CMO. Gentlemen, thank you so much for joining us. Looking forward to the discussion today.
Just want to set the stage for maybe some of the audience members that don't know your team as well. If you could just give a brief introduction on yourself, backgrounds, and then we can get some Qs about what you guys are working on over at G1.
Sounds good. Thanks for having us, Dane. We couldn't be more excited to be here. My name is Jack Bailey, as you mentioned, the CEO of G1. It was announced last fall. I had the opportunity to have the transition with my predecessor during the fall and then
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
